(Q44244686)

1 December 2017

title

Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection (English)

1 reference

1 December 2017

H Leon Bradlow

3

0 references

Yu-Tang Gao

5

object named as

Yu Tang Gao

1 reference

1 December 2017

Jay H Fowke

1

1 reference

1 December 2017

Dai Qi

2

1 reference

1 December 2017

Xiao Ou Shu

4

1 reference

1 December 2017

Jin Rong Cheng

6

1 reference

1 December 2017

Fan Jin

7

1 reference

1 December 2017

Wei Zheng

8

1 reference

1 December 2017

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

68

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

65-72

1 reference

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Functional role of estrogen metabolism in target cells: review and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Estrogen metabolism and risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Abnormal oxidative metabolism of estradiol in women with breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Weight gain in women diagnosed with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Eating pathology and obesity in women at risk for breast cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Treatment failure and dietary habits in women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Within-person variability of the ratios of urinary 2-hydroxyestrone to 16alpha-hydroxyestrone in Caucasian women.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

The effect of diurnal and menstrual cyclicity and menopausal status on estrogen metabolites: implications for disease-risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Application of an improved ELISA assay to the analysis of urinary estrogen metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Re: Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Effects of dietary broccoli on human in vivo drug metabolizing enzymes: evaluation of caffeine, oestrone and chlorzoxazone metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

4-Hydroxycatecholestrogen metabolism responses to exercise and training: possible implications for menstrual cycle irregularities and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

Plasma 2-hydroxycatecholestrogen responses to acute submaximal and maximal exercise in untrained women

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2802%2900116-2

7 January 2021

10.1016/S0039-128X(02)00116-2

Identifiers

DOI

1 reference

1 December 2017

1 reference